Facebook
Twitter
Telegram
Report an ErrorAgile Therapeutics Financial Statements 2011-2024 | AGRX
Annual Financial Statements Agile Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.29 M | 259 K | 678 K | 247 M | 187 M | 28.9 M | 101 M | 63.9 M | 134 M | 99.1 M | - | - | - |
Shares |
2.16 M | 432 K | 48.5 K | 87.4 M | 49.4 M | 34.3 M | 30.9 M | 28.3 M | 22 M | 11.4 M | - | - | - |
Historical Prices |
0.6 | 0.6 | 14 | 113 | 148 | 32.4 | 131 | 92 | 244 | 348 | - | - | - |
Net Income |
-14.5 M | -25.4 M | -71.1 M | -51.9 M | -18.6 M | -19.8 M | -28.3 M | -28.7 M | -30.3 M | -16.1 M | -14.3 M | -23.3 M | - |
Revenue |
19.6 M | 10.9 M | 4.1 M | 749 K | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
8.98 M | 6.84 M | 10.7 M | 282 K | - | - | - | - | - | - | - | - | - |
Gross Profit |
10.6 M | 4.05 M | -6.62 M | 467 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-19.9 M | -52.6 M | -71 M | -49.1 M | -18.9 M | -19.5 M | -26.8 M | -29.7 M | -33.1 M | -18.5 M | -12.7 M | -23.3 M | - |
Interest Expense |
1.42 M | 3.13 M | 3.91 M | 3.11 M | - | 1.12 M | 1.92 M | 2.45 M | 2.08 M | 1.57 M | 1.51 M | 140 K | - |
EBITDA |
-19.8 M | -51.3 M | -68.9 M | -48.8 M | -18.7 M | -18.5 M | -26.8 M | -29.7 M | -33.1 M | -18.5 M | -12.7 M | -23.3 M | - |
Operating Expenses |
30.5 M | 56.6 M | 64.4 M | 49.5 M | 18.9 M | 18.5 M | 26.8 M | 29.7 M | 33.1 M | 18.5 M | - | - | - |
General and Administrative Expenses |
10.5 M | 11.9 M | 14.7 M | 12.7 M | 9 M | 8.74 M | 12.4 M | 8.79 M | 7.47 M | 5.15 M | 3.57 M | 5.93 M | - |
All numbers in USD currency
Quarterly Income Statement Agile Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.95 M | 1.77 M | 912 K | 859 K | 740 K | 90.2 K | 62.3 K | 3.03 M | 2.34 M | 2.22 M | 2.19 M | 87.6 M | 87.4 M | 87.2 M | 76.7 M | 69.8 M | 53.6 M | 43.8 M | 37.3 M | 34.4 M | 34.4 M | 34.3 M | 34.2 M | 34.2 M | 31.9 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 28.7 M | 26.8 M | 22.3 M | 22.3 M | 22.2 M | 21.3 M | 18.6 M | 18.6 M | 8 M | 106 K | 104 K | 51.5 K | 51.5 K | - | - | - | - | - | - | - | - | - |
Net Income |
-799 K | -3.81 M | -5.39 M | - | -5.93 M | -5.17 M | -10.4 M | - | -16.8 M | -17.6 M | -17.1 M | -17.6 M | -15.5 M | -10.8 M | -7.88 M | -6.02 M | -4.43 M | -3.48 M | -4.67 M | -3.81 M | -3.79 M | -5.34 M | -6.83 M | -6.24 M | -7.1 M | -7.45 M | -7.52 M | -5.2 M | -7.8 M | -8.42 M | -7.32 M | -3.9 M | -9.41 M | -8.49 M | -8.54 M | -6.84 M | -6.35 M | -3.72 M | 839 K | -2.4 M | -3.69 M | -3.62 M | -4.61 M | - | - | - | - | - | - | - | - |
Revenue |
6.66 M | 5.5 M | 3.81 M | - | 3 M | 2.13 M | 1.76 M | - | 1.29 M | 1.18 M | 116 K | 749 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
2.48 M | 2.31 M | 2 M | - | 1.42 M | 2.23 M | 1.53 M | - | 2.71 M | 1.14 M | 1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
4.18 M | 3.2 M | 1.81 M | - | 1.58 M | -105 K | 234 K | - | -1.42 M | 40 K | -1.04 M | 467 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4 M | -5.13 M | -6.71 M | - | -18.7 M | -11.4 M | -15.6 M | - | -15.8 M | -16.7 M | -16.2 M | - | -14.7 M | -10 M | -7.62 M | - | -4.5 M | -3.55 M | -4.71 M | - | -3.62 M | -5.15 M | -7.05 M | - | -6.7 M | -7 M | -7.13 M | - | -7.09 M | -7.84 M | -6.98 M | - | -8.96 M | -7.98 M | -6.98 M | - | -6.05 M | -3.49 M | -2.45 M | - | -3.32 M | -3.25 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
341 K | 372 K | 402 K | - | 1 M | 823 K | 872 K | - | 999 K | 993 K | 922 K | - | 905 K | 902 K | 398 K | - | - | - | - | - | 268 K | 320 K | 368 K | - | 459 K | 504 K | 546 K | - | 784 K | 548 K | 548 K | - | 551 K | 547 K | 425 K | - | 392 K | 403 K | 378 K | - | 378 K | 378 K | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -6.68 M | - | -17.5 M | -10.3 M | -15 M | - | -14.2 M | -15.6 M | -15.7 M | - | -14.6 M | -10 M | -7.61 M | - | -4.48 M | -3.54 M | -4.7 M | - | -3.6 M | -5.14 M | -7.04 M | - | -6.68 M | -6.98 M | -7.12 M | - | -7.08 M | -7.83 M | -6.98 M | - | -8.95 M | -7.97 M | -6.97 M | - | -6.04 M | -3.49 M | -2.45 M | - | -3.31 M | -3.24 M | - | - | - | - | - | - | - | - | - |
Operating Expenses |
8.18 M | 8.32 M | 8.52 M | - | 20.3 M | 11.3 M | 15.8 M | - | 14.4 M | 16.7 M | 15.2 M | 17.2 M | 14.7 M | 10 M | 7.62 M | 6.1 M | 4.5 M | 3.55 M | 4.71 M | 3.73 M | 3.62 M | 5.15 M | 7.05 M | 5.99 M | 6.7 M | 7 M | 7.13 M | 7.81 M | 7.09 M | 7.84 M | 6.98 M | 9.16 M | 8.96 M | 7.98 M | 6.98 M | 6.52 M | 6.05 M | 3.5 M | 2.45 M | 1.93 M | 3.32 M | 3.25 M | 4.23 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.68 M | 3.05 M | 3.08 M | - | 2.82 M | 3.03 M | 4 M | - | 3.37 M | 3.85 M | 3.8 M | - | 3.27 M | 3.23 M | 2.71 M | - | 2.14 M | 1.77 M | 1.83 M | - | 1.77 M | 2.32 M | 3.09 M | - | 3.53 M | 3.2 M | 2.4 M | - | 2.18 M | 2.26 M | 2.05 M | - | 1.8 M | 1.81 M | 1.6 M | - | 1.45 M | 1.1 M | 1.05 M | - | 923 K | 823 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency